370 related articles for article (PubMed ID: 32062656)
1. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
[TBL] [Abstract][Full Text] [Related]
2. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
[TBL] [Abstract][Full Text] [Related]
3. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
[TBL] [Abstract][Full Text] [Related]
5. 123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases.
Nuvoli S; Tanda G; Stazza ML; Palumbo B; Frantellizzi V; De Vincentis G; Spanu A; Madeddu G
Curr Alzheimer Res; 2021; 18(3):196-207. PubMed ID: 34102975
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT findings in a case of a semantic variant of primary progressive aphasia.
Ince S; Eroglu E; Karacalioglu AO; Emer O; Alagoz E
Hell J Nucl Med; 2015; 18(2):163-5. PubMed ID: 26187219
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
[TBL] [Abstract][Full Text] [Related]
8. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
[TBL] [Abstract][Full Text] [Related]
9. Dual-phase
Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
[TBL] [Abstract][Full Text] [Related]
10. The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy.
Dodich A; Cerami C; Inguscio E; Iannaccone S; Magnani G; Marcone A; Guglielmo P; Vanoli G; Cappa SF; Perani D
Neuroimage Clin; 2019; 24():102009. PubMed ID: 31795064
[TBL] [Abstract][Full Text] [Related]
11. A disease-specific metabolic imaging marker for diagnosis and progression evaluation of semantic variant primary progressive aphasia.
Lu J; Huang L; Lv Y; Peng S; Xu Q; Li L; Ge J; Zhang H; Guan Y; Zhao Q; Guo Q; Chen K; Wu P; Ma Y; Zuo C
Eur J Neurol; 2021 Sep; 28(9):2927-2939. PubMed ID: 34110063
[TBL] [Abstract][Full Text] [Related]
12. High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia.
Ferrari C; Polito C; Berti V; Lombardi G; Lucidi G; Bessi V; Bagnoli S; Piaceri I; Nacmias B; Sorbi S
J Alzheimers Dis; 2019; 72(4):1089-1096. PubMed ID: 31683481
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India.
Mukku SSR; Sivakumar PT; Nagaraj C; Mangalore S; Harbishettar V; Varghese M
Asian J Psychiatr; 2019 Aug; 44():99-105. PubMed ID: 31336358
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.
Bouwman F; Orini S; Gandolfo F; Altomare D; Festari C; Agosta F; Arbizu J; Drzezga A; Nestor P; Nobili F; Walker Z; Morbelli S; Boccardi M;
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1526-1533. PubMed ID: 29744573
[TBL] [Abstract][Full Text] [Related]
16. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
[TBL] [Abstract][Full Text] [Related]
17. Visual and statistical analysis of ¹⁸F-FDG PET in primary progressive aphasia.
Matías-Guiu JA; Cabrera-Martín MN; Pérez-Castejón MJ; Moreno-Ramos T; Rodríguez-Rey C; García-Ramos R; Ortega-Candil A; Fernandez-Matarrubia M; Oreja-Guevara C; Matías-Guiu J; Carreras JL
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):916-27. PubMed ID: 25647075
[TBL] [Abstract][Full Text] [Related]
18. Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [
Franceschi AM; Naser-Tavakolian K; Clifton M; Bangiyev L; Cruciata G; Clouston S; Franceschi D
World J Nucl Med; 2021; 20(3):294-304. PubMed ID: 34703399
[TBL] [Abstract][Full Text] [Related]
19. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
20. [
Josephs KA; Martin PR; Botha H; Schwarz CG; Duffy JR; Clark HM; Machulda MM; Graff-Radford J; Weigand SD; Senjem ML; Utianski RL; Drubach DA; Boeve BF; Jones DT; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Whitwell JL
Ann Neurol; 2018 Mar; 83(3):599-611. PubMed ID: 29451323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
